Indeed, catalase levels were shown to be robustly and significantly decreased for PDT (p < 0.001), T2D (p < 0.01), and T2D-PDT (p < 0.0001) groups when compared to the control (Figure 3C), suggesting reduced catalase antioxidant defense in all patients. Here, CAT is linked to type 2 diabetes mellitus.